Your FMEA Is a Snapshot. The FDA Wants a Movie.

The companies that are ready for their next inspection aren't the ones with the most sophisticated FMEA software. They're the ones where complaint data flows into the risk file

VirtualBackroom Is Live — Free Trial for QMSR Prep Subscribers

QMSR Implementation & Inspection Readiness: A Comprehensive Fact-Check and Operational Analysis of the February 2, 2026, Transition

The transition to QMSR is not merely a bureaucratic exercise in updating citations; it represents a fundamental philosophical pivot from a compliance-based model to a risk-centric, Total Product Life Cycle (TPLC) regulatory framework.4

FDA Compliance Program 7382.850: The definitive guide to medical device inspections under QMSR

Beginning February 2, 2026, FDA inspections of medical device manufacturers fundamentally changed. The new Compliance Program 7382.850 (CP 7382.850) replaces both the QSIT methodology and CP 7382.845

The 30-Day Trap: How Speed Corrupts Risk Definition

In the world of Quality Management, there is no metric more comforting than the CAPA Closure Rate. When the dashboard shows "98% Closed on Time," Management Review feels safe. The metric is green. The system is working.

The CAPA Paradox: Why "Closing it Fast" is Killing Your Quality Culture

We have all sat in that Management Review meeting. The slide comes up: “CAPA Closure Rate: 98% (Target: 95%).” Everyone nods. The metric is green. The job is done.

Building Your First QMSR-Compliant QMS from Scratch

If you're a medical device startup building your first quality management system, you have an advantage: you can build it right from the start. You're not transitioning from QSR to QMSR—you're starting fresh with QMSR requirements as your foundation.

QMSR Supplier Quality Requirements: Complete Management Guide

Supplier quality management under QMSR is more explicitly risk-based than under QSR. ISO 13485:2016 Clause 7.4 requires

QMSR Compliance: Common Mistakes and How to Avoid Them

With the February 2, 2026 deadline approaching, companies are rushing to implement QMSR requirements. Speed creates risk. We're already seeing patterns of mistakes that will likely result in FDA findings—or worse, will require expensive rework after the deadline.